April: CEO Update

An update from AgPlus Diagnostics CEO Fiona Marshall:

Welcome to the latest edition of our update, time is marching on as we move through May and the Team at AgPlus continue to work hard as we step through the integration of assay chemistry onto cartridge in our Agilis™ reader platform. We are on track to work with key partners to complete usability trials through Q2 and Q3 allowing us to progress forward with design for manufacture of the Agilis™ Platform. Working closely with our reader supplier (STI) we will incorporate the feedback from the usability trials to meet end user requirements.

We recently were lucky enough to get some grant support from the National Physical Laboratory and working closely with them we have been further investigating alternative metal ions for electrochemistry and how this may fit in with multiplex assays.

This month’s white paper takes a look at the benefits of Point of Care (PoC) testing for assessment of faecal Calprotectin levels in the diagnosis of Inflammatory Bowel Disease (IBD). We are delighted that Dr James Lee, Wellcome Trust Intermediate Clinical Fellow and Honorary Consultant Gastroenterologist at Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge agreed to contribute his thoughts around the current challenges of testing for faecal Calprotectin and the benefits a point of care system could add to discriminating IBD from Irritable Bowel Syndrome (IBS).

We are very excited to introduce you to our new Quality Manager in our Meet the Team this month. Sandeep, or Sunny as he prefers, joined in March and he is certainly adding some shine to our Quality Management System, getting us up to speed for our ISO 13485 scope change at the end of the year so that we can offer contract manufacturing services to our customers.

Please get in touch if you would like to collaborate

Thank you for taking the time to read the update and hope you enjoy the white paper.

Kind Regards